Comments on:

Court: Can drug companies pay to delay generics?

Back to the article » |
WASHINGTON (AP) — Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines that can top 90 percent. The Obama administration, backed by consumer groups and the American...